PDA Device Closure procedure in India. The ductus arteriosus is present in all foetuses enabling blood to bypass the non-working lungs. During childbirth or not long after birth as the infant inhales, the Ductus Arteriosus would usually close permanently. Inability to do so outcomes in Patent Ductus Arteriosus (PDA) which is an open channel enabling blood to flow out of the aorta (vein carrying blood from the heart to the entire body) to the pulmonary artery (vein supplying the lung).
The report "Vascular Closure Device Market by Type (Passive Approximators (Collagen Plugs Sealent/Gel Based), Active Approximators (Clip, Suture Devices)), Access (Femoral,Radial) & Procedure (Interventional Cardiology, Radiology) - Global Forecasts to 2022", report provides a detailed overview of the major drivers, restraints, opportunities, and threats impacting the vascular closure devices market along with the estimates and forecasts of the revenue and market share analysis.Browse 61 market data tables and 30 figures spread through 128 pages and in-depth TOC on "Vascular Closure Device Market by Type (Passive Approximators (Collagen Plugs Sealent/Gel Based), Active Approximators (Clip, Suture Devices)), Access (Femoral,Radial) & Procedure (Interventional Cardiology, Radiology) - Global Forecasts to 2022"Get Free PDF - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180101468The global vascular closure devices market is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%.
Growth in this market can be attributed to factors such as the large number of approvals for vascular closure devices, high prevalence of cardiovascular diseases and obesity, and increasing focus of market players on large-bore vascular closure devices.The market is segmented on the basis of type, access type, procedure type, and regions.
Based on type, the market segment is further categorized into active approximators, passive approximators, and external hemostasis devices.
Passive approximators are expected to account for the largest share of the market in 2017.
Collagen-based passive approximators are widely used owing to the wide range of advantages associated with these devices, including ease of use, short ambulation time for patients, and fewer complications compared to manual compression.The market is segmented into North America, Europe, Asia-Pacific, and RoW (Rest of the World).
Of these, the North American segment is expected to account the largest share of the market in 2017.
Left Atrial Appendage Closure Device Market report published by Value Market Research, which studies the future outlook of the market.
It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2020-2027.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the left atrial appendage closure device market include Boston Scientific Corporation, AtriCure, St. Jude Medical, Lifetech Scientific (Shenzhen), Coherex Medical.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Left Atrial Appendage Closure Device Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/left-atrial-appendage-closure-device-market/download-sampleMarket DynamicsStroke is a serious risk for patients with atrial fibrillation.
Atrial fibrillation (AFib) is the most widely recognized heart rhythm abnormality, affecting more than 33 million individuals around the world.
Also, Surge in government initiatives to raise public awareness related to cardiovascular diseases and attractive health insurance policies are likely to influence the growth of left atrial appendage closure device market.
According to a recently published market study by Future Market Insights, the global market for vascular closure devices will expand steadily at a CAGR of 5.9% and reach US$ 963 million over the forecast period, 2017-2022.
“Vascular Closure Devices Market Research Report – Forecast to 2022” Published by Market Research Future.
Vascular Closure Devices Market Research Report, by Product Type (Passive Vascular Closure Device, Active Vascular Closure Device, External Hemostatic Device), Access (Femoral, Radial), Procedures (Interventional Cardiology, Interventional Radiology), Application (Diagnostic, Therapeutic), End User (Hospitals & Clinics, ASCs) – Global Forecast Till 2022Companies to WatchCompanies namely, Abbott Laboratories, Terumo Corporation, Cardinal Health, Inc., Medtronic plc, Cardiva Medical, Inc., Arstasis, Inc., Chitogen, Inc., Marine Polymer Technologies, Inc., Essential Medical, Inc., Scion Cardio-Vascular, Inc., Morris Innovative, Inc., Tricol Biomedical, Inc., Vascular Closure Systems, Inc., and TZ Medical, Inc. are profiled in the report as key players in the global vascular closure devices market.Vascular Closure Devices Market Overview The increased approvals for vascular closure devices, support, and initiatives by the government, soaring demand for advanced treatment, and rising research and clinical trials are some of the primary growth stimulants of the vascular closure devices market.
Factors like the rising prevalence of obesity and soaring incidences of cardiovascular diseases will contribute to the market growth in the review period.
The increased popularity of femoral artery cardiac catheterization, shortening of hemostasis time, and increased success rate of VCDs for improved patient comfort are considered some of the potential growth factors of the market.Download Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1809Market TaxonomyThe taxonomy of the global vascular closure device market has been concisely illustrated in the table below:RegionNorth AmericaLatin AmericaEuropeJapanAPEJMEAProduct TypeHaemostasis PadsCompression DevicesClipPlugSutureOthersEnd UserHospitalsAmbulatory Surgical CentresIndependent Catheterisation LabsAsk an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-1809Regional Vascular Closure Devices (VCDS) Market (Regional Output, Demand & Forecast by Countries):-North America (United States, Canada, Mexico)South America ( Brazil, Argentina, Ecuador, Chile)Asia Pacific (China, Japan, India, Korea)Europe (Germany, UK, France, Italy)Middle East Africa (Egypt, Turkey, Saudi Arabia, Iran) And More.Table of Contents:Chapter 1.
Market Introduction2.1 Definition2.2 Scope Of The Study2.2.1 Research Objective2.2.2 Assumptions2.2.3 LimitationsAsk for TOC @ https://www.futuremarketinsights.com/toc/rep-gb-1809Chapter 3.
The Left Atrial Appendage Closure Device Market research report provides the latest industry data, growth, key segments and future trends on the basis of the detailed study.
This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countries.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the left atrial appendage closure device market include Boston Scientific Corporation, AtriCure, St. Jude Medical, Lifetech Scientific (Shenzhen), Coherex Medical.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Left Atrial Appendage Closure Device Market Research Report" by requesting FREE Sample Copy athttps://www.valuemarketresearch.com/contact/left-atrial-appendage-closure-device-market/download-sampleMarket DynamicsStroke is a serious risk for patients with atrial fibrillation.
Atrial fibrillation (AFib) is the most widely recognized heart rhythm abnormality, affecting more than 33 million individuals around the world.
Also, Surge in government initiatives to raise public awareness related to cardiovascular diseases and attractive health insurance policies are likely to influence the growth of left atrial appendage closure device market.
